JP2004504409A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004504409A5 JP2004504409A5 JP2002514243A JP2002514243A JP2004504409A5 JP 2004504409 A5 JP2004504409 A5 JP 2004504409A5 JP 2002514243 A JP2002514243 A JP 2002514243A JP 2002514243 A JP2002514243 A JP 2002514243A JP 2004504409 A5 JP2004504409 A5 JP 2004504409A5
- Authority
- JP
- Japan
- Prior art keywords
- active substances
- acidic
- acid
- pharmaceutically active
- fluorobiprofene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 description 5
- 230000002378 acidificating Effects 0.000 description 3
- DKYWVDODHFEZIM-UHFFFAOYSA-N Ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- PCZOHLXUXFIOCF-BXMDZJJMSA-N Lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
Description
「酸性薬学的活性物質」の用語は、それらの分子構造中に、ルイス酸として化学的に反応することができる少なくとも１個の基を有する医薬活性物質を意味するものと理解する。好ましくは、このような基は、酸性カルボニル官能性基を有する。例には、カルボン酸類、アセチルサリチル酸、デヒドロコリン酸、ケトプロフェン（ketoprofene）、ロバスタチン（lovastatine）およびフルオロビプロフェン（fluorobiprofene）がある。
しかしながら、酸性または塩基性活性物質とは別に、経皮投与に適する別種の活性物質を、本発明による医療用感圧接着剤に配合し、経皮治療系用の活性物質マトリックスを生成することができる。
しかしながら、酸性または塩基性活性物質とは別に、経皮投与に適する別種の活性物質を、本発明による医療用感圧接着剤に配合し、経皮治療系用の活性物質マトリックスを生成することができる。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10035891A DE10035891A1 (de) | 2000-07-24 | 2000-07-24 | Medizinischer Haftkleber mit einer zweiphasigen Klebermatrix aus Polyacrylaten und Polyaminsalzen |
| PCT/EP2001/007982 WO2002008352A1 (de) | 2000-07-24 | 2001-07-11 | Medizinischer haftkleber mit einer zweiphasigen klebermatrix aus polyacrylaten und polyaminsalzen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004504409A JP2004504409A (ja) | 2004-02-12 |
| JP2004504409A5 true JP2004504409A5 (ja) | 2007-02-22 |
| JP4663209B2 JP4663209B2 (ja) | 2011-04-06 |
Family
ID=7649960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002514243A Expired - Fee Related JP4663209B2 (ja) | 2000-07-24 | 2001-07-11 | ポリアクリレートおよびポリアミン塩の２相接着剤マトリックスを含有する医療用接触接着性組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6936661B2 (ja) |
| EP (1) | EP1305378B1 (ja) |
| JP (1) | JP4663209B2 (ja) |
| KR (1) | KR100660584B1 (ja) |
| AT (1) | ATE310061T1 (ja) |
| DE (2) | DE10035891A1 (ja) |
| ES (1) | ES2253408T3 (ja) |
| WO (1) | WO2002008352A1 (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101087346B1 (ko) | 2004-02-19 | 2011-11-25 | 에스케이케미칼주식회사 | 자기발열체용 피부 점착성 조성물 및 이것이 부착된자기발열체 |
| ITMI20041628A1 (it) * | 2004-08-06 | 2004-11-06 | Bouty S P A | Sistema terapeutico a rilascio controllato per uso topico transdermico |
| US7829116B2 (en) * | 2006-11-14 | 2010-11-09 | Momentive Performance Materials Inc. | Adhesive-forming composition and blend of adhesives obtained therefrom |
| US7976951B2 (en) | 2006-11-14 | 2011-07-12 | Momentive Performance Materials Inc. | Laminate containing an adhesive-forming composition |
| TR201001461T1 (tr) * | 2007-08-27 | 2011-01-21 | Jaymore Enterprises Limited | Katater klipsi |
| GB0809905D0 (en) * | 2008-06-02 | 2008-07-09 | Secr Defence | A Transdermal drug delivery device |
| US8366600B2 (en) * | 2008-06-19 | 2013-02-05 | Nupathe Inc. | Polyamine enhanced formulations for triptan compound iontophoresis |
| MX351262B (es) * | 2008-06-19 | 2017-10-06 | Lts Lohmann Therapie Systeme Ag Star | Composicion para el transporte transdermico de agentes activos cationicos. |
| UA103851C2 (en) | 2010-04-30 | 2013-11-25 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. | Propylaminoindan transdermal composition |
| CN103476404B (zh) | 2011-03-24 | 2017-09-29 | 帝国制药美国公司 | 包含活性剂层和活性剂转化层的透皮组合物 |
| EP2776020B1 (en) | 2011-11-09 | 2019-09-11 | Teikoku Seiyaku Co., Ltd. | Methods for the treatment of skin neoplasms |
| AU2013338243B2 (en) | 2012-11-02 | 2016-09-29 | Teikoku Seiyaku Co., Ltd. | Propynylaminoindan transdermal compositions |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2693212B2 (ja) * | 1989-03-28 | 1997-12-24 | 日東電工株式会社 | 疾患治療用テープ製剤 |
| DE3924393A1 (de) * | 1989-07-24 | 1991-01-31 | Roehm Gmbh | Wasserloeslicher druckempfindlicher hauthaftkleber, dessen verwendung und damit ausgeruestete mittel |
| JP3046346B2 (ja) * | 1990-03-12 | 2000-05-29 | 昭和電工株式会社 | 外用剤基剤又は補助剤とそれを含有する人又は動物の外用剤 |
| US5977242A (en) * | 1992-11-24 | 1999-11-02 | Konishi Co., Ltd. | Two-part emulsion adhesive |
| JPH06322342A (ja) | 1993-05-12 | 1994-11-22 | Konishi Kk | 二液型接着剤組成物 |
| DE4429791C2 (de) * | 1994-08-23 | 1997-04-24 | Lohmann Therapie Syst Lts | Medizinischer Haftkleber auf Basis von Polyacrylaten und dessen Verwendung |
| JPH09143061A (ja) * | 1995-11-20 | 1997-06-03 | Showa Denko Kk | 鎮痛剤用経皮吸収製剤 |
| DE19918105C1 (de) * | 1999-04-22 | 2000-09-21 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit einem stark wirksamen Neuroleptikum |
-
2000
- 2000-07-24 DE DE10035891A patent/DE10035891A1/de not_active Withdrawn
-
2001
- 2001-07-11 ES ES01956526T patent/ES2253408T3/es not_active Expired - Lifetime
- 2001-07-11 WO PCT/EP2001/007982 patent/WO2002008352A1/de active IP Right Grant
- 2001-07-11 JP JP2002514243A patent/JP4663209B2/ja not_active Expired - Fee Related
- 2001-07-11 EP EP01956526A patent/EP1305378B1/de not_active Expired - Lifetime
- 2001-07-11 DE DE50108099T patent/DE50108099D1/de not_active Expired - Lifetime
- 2001-07-11 KR KR1020037001030A patent/KR100660584B1/ko active IP Right Grant
- 2001-07-11 US US10/333,783 patent/US6936661B2/en not_active Expired - Lifetime
- 2001-07-11 AT AT01956526T patent/ATE310061T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004504409A5 (ja) | ||
| RU2470016C2 (ru) | Производное бипиразола | |
| CA2382387A1 (en) | Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure | |
| IT1303735B1 (it) | Acidi ialuronici reticolati e loro usi medici. | |
| MY142403A (en) | Oral dosage forms for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient | |
| JP2009536147A5 (ja) | ||
| IL160253A0 (en) | Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient | |
| DK1135112T3 (da) | Oral formulering til gastrointestinal lægemiddeladministration | |
| WO2008021088A3 (en) | Salicylanilides enhance oral delivery of therapeutic peptides | |
| WO2005107719A3 (en) | Pharmaceutical composition comprising hydrophobic drug having improved solubility | |
| DK1460992T3 (da) | Stabiliserede omvendte micellesammensætninger og anvendelser deraf | |
| HK1115308A1 (en) | Solid dosage form comprising proton pump inhibitor and suspension made thereof | |
| WO2004032862A3 (en) | Cyclodextrin-based materials, compositions and uses related thereto | |
| ITMI20001173A0 (it) | Composizioni farmaceutiche a rilascio prolungato per la somministrazione parenterale di sostanze idrofile biologicamente attiva. | |
| CA2297832A1 (en) | Pellet-type formulation intended for treating the intestinal tract | |
| HUP0200895A3 (en) | Benzimidazole derivatives of alpha-substituted carboxylic acids, pharmaceutical compositions containing them and their use | |
| WO2002013784A3 (en) | Drug delivery system with bilayer electrodes | |
| MY145329A (en) | Gastroresistant pharmaceutical dosage form comprising n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423) | |
| JP2005237328A5 (ja) | ||
| JP2000159790A5 (ja) | ||
| JP2004505036A5 (ja) | ||
| EP1749540A3 (en) | Compositions for improving bioavailability of orally administered drugs | |
| DK1225902T3 (da) | Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden | |
| CA2005980A1 (en) | Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation | |
| Parthasarathy et al. | Buccal mucosa a gifted choice for systemic drug delivery |